Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Dermata Therapeutics, Inc. (DRMA)  
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 8,330,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $ - $
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   Dermata Therapeutics is a clinical-stage medical dermatology company focused on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions and diseases. Co.'s main product candidate, DMT310, is intended to utilize its Spongilla technology for a once weekly treatment of a variety of skin diseases with its initial focus being for the treatment of acne vulgaris. Co.'s second product candidate utilizing its Spongilla technology is its combination treatment, DMT410. DMT410 is intended to consist of one treatment of Co.'s sponge powder followed by one topical application of botulinum toxin for delivery into the dermis.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-03-21 2023-12-19 2023-06-20 2022-06-20

   
Records found: 40
  Page 2 of 2  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Nardo Christopher J. Senior VP, Development   •       –      –    2021-08-17 4 A $0.00 $0 I/I 2,439 2,439     -
   Bedoya-Toro Maria E Senior Vice President   •       –      –    2021-08-17 4 A $0.00 $0 I/I 64,631 84,143     -
   Wierenga Wendell Director   –       •      –    2021-08-17 4 A $0.00 $0 D/D 8,163 13,041     -
   Proehl Gerald T President, CEO and Chairman   •       •       •   2021-08-16 4 B $4.96 $49,631 I/I 10,000 10,000 2.64     -
   Nardo Christopher J. Senior VP, DevelopmentOfficer   •       –      –    2021-08-12 3 IO $0.00 $0 D/D 0 25,121     -
   Proehl Gerald T Pres., CEO and ChairmanOfficer   •       –       •   2021-08-12 3 IO $0.00 $0 I/I 0 917,317     -
   Proehl Gerald T Pres., CEO and ChairmanOfficer   •       –       •   2021-08-12 3 IO $0.00 $0 D/D 0 39,512     -
   Insley Thomas Chief Financial OfficerOfficer   •       –      –    2021-08-12 3 IO $0.00 $0 I/I 0 9,756     -
   Wierenga Wendell Director   –       •      –    2021-08-12 3 IO $0.00 $0 D/D 0 4,878     -
   Scott Kathleen D. Director   –       •      –    2021-08-12 3 IO $0.00 $0 I/I 0 2,439     -
   Proehl Investment Ventures Llc 10% Owner   –       –       •   2021-08-12 3 IO $0.00 $0 D/D 0 917,317     -
   Bedoya-Toro Maria E Senior VPOfficer   •       –      –    2021-08-12 3 IO $0.00 $0 I/I 0 19,512     -
   Bedoya-Toro Maria E Senior VPOfficer   •       –      –    2021-08-12 3 IO $0.00 $0 D/D 0 30,487     -
   Hale David F Director   –       •      –    2021-08-12 3 IO $0.00 $0 I/I 0 266,829     -
   Hale David F Director   –       •      –    2021-08-12 3 IO $0.00 $0 D/D 0 3,658     -

  40 Records found
  1  2    
  Page 2 of 2
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed